Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients.
Saved in:
| Title: | Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients. |
|---|---|
| Authors: | Sokolenko, Anna P.1,2 (AUTHOR), Moiseyenko, Fedor V.3 (AUTHOR), Iyevleva, Aglaya G.1,2 (AUTHOR), Ivantsov, Alexandr O.1 (AUTHOR), Dolmatov, Georgiy D.3 (AUTHOR), Shelekhova, Ksenia V.3 (AUTHOR), Gulo, Elizaveta V.3 (AUTHOR), Topal, Anastasya X.3 (AUTHOR), Artemieva, Elizaveta V.3 (AUTHOR), Abduloeva, Nuriniso H.3 (AUTHOR), Rysev, Nikita A.3 (AUTHOR), Barsova, Daria A.3 (AUTHOR), Levchenko, Natalia V.3 (AUTHOR), Volkov, Nikita M.3 (AUTHOR), Egorenkov, Vitaliy V.3 (AUTHOR), Moiseyenko, Vladimir M.3 (AUTHOR), Imyanitov, Evgeny N.1,2,3 (AUTHOR) evgeny@imyanitov.spb.ru |
| Source: | International Journal of Molecular Sciences. Feb2023, Vol. 24 Issue 3, p1870. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
